Observational Study on Costs and Caregiver Burden in Alzheimer's Disease

NCT00698165 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2400

Last updated 2009-02-20

No results posted yet for this study

Summary

Objective of study is to assess the costs of care, objective and subjective caregiver burden and quality of life in relation to disease severity measured by cognitive function, ADL capabilities and presence of behavioral disturbances in Alzheimer's disease

Conditions

Sponsors & Collaborators

  • i3 Innovus

    collaborator INDUSTRY
  • AstraZeneca

    lead INDUSTRY

Principal Investigators

  • Linus Jönsson · i3 Innovus

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-06-30
Completion
2009-01-31

Countries

  • United States
  • Spain
  • Sweden
  • United Kingdom

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00698165 on ClinicalTrials.gov